Latest News
EBC launches 2020 Annual Report
This week, the European Brain Council launched its 2020 Annual Report. In spite of a very challenging year, we are extremely proud that we were able to carry on our activities and continue to deliver upon the agenda and objectives that were defined for the organisation. COVID-19 naturally had a major impact on many areas over 2020. The entire brain [...]
EBC and EBRAINS launch Save the Date for European Brain Summit, held in conjunction with the Brain Innovation Days and HBP Summit
The European Brain Council and the EBRAINS Research Infrastructure are pleased to invite you to the first European Brain Summit, a joint event that will take place on 12th October 2021 in Brussels from 13:30 to 18:00, in conjunction with the Brain Innovation Days and Human Brain Project Summit. This will be a unique opportunity to explore the challenge [...]
GOLUP Consortium holds a digital event on “Patient Safety and Informed Consent: The Importance of Good Off-label Use Practices”
Event Report: “Patient Safety and Informed Consent: The Importance of Good Off-label Use Practices” On 17 June 2021, the GOLUP consortium held a virtual event, led by the European Brain Council, to disseminate the Declaration on Good Off-Label Use Practices. The event was hosted by MEP Cyrus Engerer (S&D, Malta), who is a member of the public health (ENVI) committee [...]
EBC supports the need to prioritise the rapidly growing challenge of Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur, and the underlying cause in 70% of people with dementia. Dementia, which is not a specific disease but an overall term that describes a group of symptoms, is characterized by a decline in memory, thinking, behavior and the ability to [...]
New Value of Treatment stream on Transversal Topics currently underway
Kicked off in December 2020, a third stream of the Value of Treatment project on Transversal Topics is officially underway over a three-year period from 2021 to 2023. A case study on chronic pain has begun and soon a case study on sleep and wake disorders is to follow, potentially among others. The group study on chronic pain, chaired [...]
VOT2 Case Studies on Rare Diseases & Mental Disorders present findings at Synthesis Meeting on 8 June 2021
On 8 June 2021, EBC hosted a virtual Synthesis Meeting for the Value of Treatment 2 case study working groups to present their preliminary findings. The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). EBC conceptualized in 2015 the Value of Treatment research framework with [...]
EBC raises awareness on International Phenylketonuria Day
EBC is happy to recognise and support International Phenylketonuria (PKU) Day, which takes place annually on 28 June — the birthday of two stalwarts of PKU, Robert Guthrie (1916-1995) and Horst Bickel (1918-2000). The ongoing 2019-2021 Value of Treatment (VOT) project for Brain Disorders and its recent synthesis meeting on 8 June 2021 aimed to provide preliminary findings on the [...]
Save the Date and Call for Applications Launched for Brain Innovation Days
We are excited to announce that after one year of digital sessions, the Brain Innovation Days will take place in person on 12-13 October 2021 in Brussels, Belgium. Under the overarching theme, United for Brain Innovation, the Brain Innovation Days will bring together key opinion leaders and stakeholders from the ever-growing brain innovation ecosystem to create synergies and showcase the importance [...]
The Value of Treatment for Brain Disorders: Case Studies on Rare Diseases & Mental Disorders present findings at Synthesis Meeting
The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). EBC conceptualized the Value of Treatment research framework to address the increasing burden of brain disorders – both neurological and mental alike. Budgetary restrictions across the EU are threatening the sustainability of the European social welfare [...]
EBC launches “RETHINKING MS in times of COVID-19” on the occasion of World Multiple Sclerosis Day
On the occasion of the approaching World Multiple Sclerosis Day (30 May 2021), the European Brain Council is excited to announce the release of its new policy paper, "RETHINKING MS in times of COVID-19". This new paper is part of the main report "RETHINKING MS in Europe", a research-driven project offering tangible policy changes to improve the lives of [...]